Journal of Clinical Epidemiology
Volume 53, Issue 8 , Pages 823-831 , August 2000

Assessing the Saskatchewan database for outcomes research studies of depression and its treatment

  • Suzanne L West

      Affiliations

    • Research Triangle Institute, Research Triangle Park, North Carolina, USA
    • Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA
    • Corresponding Author InformationCorresponding author. University of North Carolina at Chapel Hill, North Carolina Program on Women's Health Research, Cecil G. Sheps Center for Health Services Research, 725 Airport Road, Chapel Hill, NC 27599-7590
    • ,
  • Anke Richter

      Affiliations

    • Research Triangle Institute, Research Triangle Park, North Carolina, USA
    • ,
  • Catherine A Melfi

      Affiliations

    • Health Outcomes Evaluation Group, Eli Lilly and Company, Indianapolis, IN, USA
    • Indiana University School of Medicine and Regenstrief Institute, Indianapolis, IN, USA
    • ,
  • Mary McNutt

      Affiliations

    • Research Services, Population Health Branch, Saskatchewan Health, Regina, Saskatchewan, Canada
    • ,
  • Marianne E Nennstiel

      Affiliations

    • Research Triangle Institute, Research Triangle Park, North Carolina, USA
    • ,
  • Josephine A Mauskopf

      Affiliations

    • Research Triangle Institute, Research Triangle Park, North Carolina, USA

Received 18 June 1999 ,Accepted 22 December 1999.

References 

  1. American Society of Hospital Pharmacists . AHFS Drug Information. Bethesda, MD: American Society of Hospital Pharmacists; 1998;
  2. Katz L, Fleisher W, Kjernisted K, et al.  A review of the psychobiology and pharmacotherapy of posttraumatic stress disorder. Can J Psch. 1996;41:233–238
  3. Streator SE, Moss JT. Non-approved usage identification of off-label antidepressant use and costs in a network model HMO. Drug Benefit Trends. 1997;9:42–56
  4. Breslau N, Davis GC, Schultz LR, Peterson EL. Joint 1994 Wolff Award Presentation. Migraine and major depression (A longitudinal study). Headache. 1994;34:387–393
  5. Devlen J. Anxiety and depression in migraine. J Royal Soc Med. 1994;87:338–341
  6. Gruber AJ, Hudson JI, Pope HG. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. Psychiatric Clinics of North America. 1996;19:351–369
  7. Cathebras PJ, Robbins JM, Kirmayer LJ, et al.  Fatigue in primary care (Prevalence, psychiatric comorbidity, illness behavior, and outcome). J Gen Intern Med. 1993;8:276–286
  8. Finley PR. Selective serotonin reuptake inhibitors (Pharmacologic profiles and potential therapeutic distinctions). Annals of Pharmacotherapy. 1994;28:1359–1369
  9. World Health Organization . The International Classification of Diseases, 9th revision, Clinical Modification. 4th edition. Geneva, Switzerland: World Health Organization; 1996;
  10. Browne RA, Melfi CA, Croghan TW, et al.  Issues to consider when conducting research using physician-reported antidepressant claims. Drug Benefit Trends. 1998;10:33–42
  11. Malcolm E, Downey W, Strand LM, McNutt M, West R. Saskatchewan Health's linkable databases and pharmacoepidemiology. PMS. 1993;6:175–264
  12. Strand LM, Downey W. Health databases in Saskatchewan. In:  Strom B editors. Pharmacoepidemiology. 2nd Edition. Chichester, UK: John Wiley & Sons; 1994;p. 217–229
  13. SAS Institute, Inc . SAS User's Guide, Version 6. Cary, NC: SAS Institute, Inc; 1990;
  14. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174
  15. West SL, Strom BL, Freundlich B, et al.  Completeness of prescription recording in outpatient medical records from a Health Maintenance Organization. J Clin Epidemiol. 1994;47:165–171
  16. West SL, Strom BL. Validity of pharmacoepidemiology drug and diagnosis data. In:  Strom BL editors. Pharmacoepidemiology. 2nd Edition. Chichester, UK: John Wiley & Sons; 1994;
  17. Rawson NSB, Malcolm E, D'Arcy C. Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles. Soc Psych Psychiatric Epidemiol. 1997;32:191–199
  18. Croghan TW, Lair TJ, Engelhart L, Crown WE, Copley-Merriman C, Melfi CA, et al. Effect of antidepressant therapy on health care utilization and costs in primary care. Psych Services. 1997;48:1420–1426
  19. Thompson D, Buesching D, Gregor KJ, Oster G. Patterns of antidepressant use and their relation to costs of care. Am J Man Care. 1996;2:1239–1246

PII: S0895-4356(99)00237-1

Journal of Clinical Epidemiology
Volume 53, Issue 8 , Pages 823-831 , August 2000

Article Tools